Ignite Creation Date:
2024-10-26 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 3:41 PM
Study NCT ID:
NCT06615622
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-09-19
Brief Title:
Our Study Aims to Determine If Nerve Alterations in Acute GBS and CIDP Detectable by Ultrasound Match Electrodiagnostic Findings and If This Method Aids Early Diagnosis Predict Their Outcomes and Differentiate Between Axonal and Demyelinating Subtypes
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Comparative Study of Peripheral Nerve Ultrasound Findings in Immune Mediated Peripheral Nerve Disorders a Hospital-based Study
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Neuromuscular ultrasound NMUS is emerging as a valuable non-invasive diagnostic tool In GBS NMUS can detect proximal nerve enlargement early before neurophysiological changes Persistent nerve enlargement can be observed up to 15 years though its correlation with disability varies Research is needed to clarify NMUS findings in GBS and CIDP over time Early detection of nerve root enlargement via NMUS could facilitate earlier diagnosis and intervention improving patient outcomes and understanding of these conditionsamp39 pathophysiology
This study aims to determine if nerve alterations in acute GBS and CIDP detectable by ultrasound match electrodiagnostic findings and if this method aids early diagnosis The investigators will perform serial nerve ultrasounds and NCS to investigate nerve morphology predict outcomes and differentiate between axonal and demyelinating subtypes
This study aims to determine if nerve alterations in acute GBS and CIDP detectable by ultrasound match electrodiagnostic findings and if this method aids early diagnosis The investigators will perform serial nerve ultrasounds and NCS to investigate nerve morphology predict outcomes and differentiate between axonal and demyelinating subtypes
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None